Terms: = Breast cancer AND HOXC11, HOX3H, 3227, ENSG00000123388, O43248
19 results:
1. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract] [Full Text] [Related]
2. Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.
Rebbeck CA; Xian J; Bornelöv S; Geradts J; Hobeika A; Geiger H; Alvarez JF; Rozhkova E; Nicholls A; Robine N; Lyerly HK; Hannon GJ
Nat Commun; 2022 Jun; 13(1):3399. PubMed ID: 35697697
[TBL] [Abstract] [Full Text] [Related]
3. Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification.
Ho PJ; Ho WK; Khng AJ; Yeoh YS; Tan BK; Tan EY; Lim GH; Tan SM; Tan VKM; Yip CH; Mohd-Taib NA; Wong FY; Lim EH; Ngeow J; Chay WY; Leong LCH; Yong WS; Seah CM; Tang SW; Ng CWQ; Yan Z; Lee JA; Rahmat K; Islam T; Hassan T; Tai MC; Khor CC; Yuan JM; Koh WP; Sim X; Dunning AM; Bolla MK; Antoniou AC; Teo SH; Li J; Hartman M
BMC Med; 2022 Apr; 20(1):150. PubMed ID: 35468796
[TBL] [Abstract] [Full Text] [Related]
4. Brain Metastases among cancer Patients Diagnosed from 2010-2017 in Canada: Incidence Proportion at Diagnosis and Estimated Lifetime Incidence.
Liu JL; Walker EV; Paudel YR; Davis FG; Yuan Y
Curr Oncol; 2022 Mar; 29(3):2091-2105. PubMed ID: 35323369
[TBL] [Abstract] [Full Text] [Related]
5. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
[TBL] [Abstract] [Full Text] [Related]
6. Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients.
Liu K; Huang G; Chang P; Zhang W; Li T; Dai Z; Lv Y
Sci Rep; 2020 Dec; 10(1):21376. PubMed ID: 33288828
[TBL] [Abstract] [Full Text] [Related]
7. Certain haplotypes of the 3'-UTR region of the HLA-G gene are linked to breast cancer.
Haghi M; Ranjbar M; Karari K; Samadi-Miandoab S; Eftekhari A; Hosseinpour-Feizi MA
Br J Biomed Sci; 2021 Apr; 78(2):87-91. PubMed ID: 33237834
[No Abstract] [Full Text] [Related]
8. breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS).
Gooch JC; Chun J; Kaplowitz E; Kurz E; Guth A; Lee J; Schnabel F
Ann Surg Oncol; 2019 Oct; 26(11):3472-3477. PubMed ID: 31147991
[TBL] [Abstract] [Full Text] [Related]
9. Induction of a novel isoform of the lncRNA HOTAIR in Claudin-low breast cancer cells attached to extracellular matrix.
Li M; Li X; Zhuang Y; Flemington EK; Lin Z; Shan B
Mol Oncol; 2017 Dec; 11(12):1698-1710. PubMed ID: 28846832
[TBL] [Abstract] [Full Text] [Related]
10. Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.
Ali A; Creevey L; Hao Y; McCartan D; O'Gaora P; Hill A; Young L; McIlroy M
Breast Cancer Res; 2015 Sep; 17(1):123. PubMed ID: 26341737
[TBL] [Abstract] [Full Text] [Related]
11. Impact of inflammatory markers on the prognosis of patients with operable breast cancer.
Petekkaya I; Aksoy S; Roach EC; Okoh AK; Gecmez G; Gezgen G; Isler DC; Dogan E; Babacan T; Sarici F; Petekkaya E; Altundag K
J BUON; 2014; 19(3):673-80. PubMed ID: 25261651
[TBL] [Abstract] [Full Text] [Related]
12. Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.
Walsh CA; Bolger JC; Byrne C; Cocchiglia S; Hao Y; Fagan A; Qin L; Cahalin A; McCartan D; McIlroy M; O'Gaora P; Xu J; Hill AD; Young LS
Cancer Res; 2014 May; 74(9):2533-44. PubMed ID: 24648347
[TBL] [Abstract] [Full Text] [Related]
13. Fibrotic changes after postmastectomy radiotherapy and reconstructive surgery in breast cancer. A retrospective analysis in 109 patients.
Classen J; Nitzsche S; Wallwiener D; Kristen P; Souchon R; Bamberg M; Brucker S
Strahlenther Onkol; 2010 Nov; 186(11):630-6. PubMed ID: 21072625
[TBL] [Abstract] [Full Text] [Related]
14. Interaction of developmental transcription factor hoxc11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected].
McIlroy M; McCartan D; Early S; O Gaora P; Pennington S; Hill AD; Young LS
Cancer Res; 2010 Feb; 70(4):1585-94. PubMed ID: 20145129
[TBL] [Abstract] [Full Text] [Related]
15. A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer.
Rocca A; Peruzzotti G; Ghisini R; Viale G; Veronesi P; Luini A; Intra M; Pietri E; Curigliano G; Giovanardi F; Maisonneuve P; Goldhirsch A; Colleoni M
Anticancer Drugs; 2006 Nov; 17(10):1201-9. PubMed ID: 17075320
[TBL] [Abstract] [Full Text] [Related]
16. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells.
Rahbar AM; Fenselau C
J Proteome Res; 2005; 4(6):2148-53. PubMed ID: 16335961
[TBL] [Abstract] [Full Text] [Related]
17. Aberrant expression of HOX genes in human invasive breast carcinoma.
Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
[TBL] [Abstract] [Full Text] [Related]
18. Characterization of a CCAAT-enhancer element of trefoil factor family 2 (TFF2) promoter in MCF-7 cells.
Chi AL; Lim S; Wang TC
Peptides; 2004 May; 25(5):839-47. PubMed ID: 15177880
[TBL] [Abstract] [Full Text] [Related]
19. Risk factors for breast cancer.
Helmrich SP; Shapiro S; Rosenberg L; Kaufman DW; Slone D; Bain C; Miettinen OS; Stolley PD; Rosenshein NB; Knapp RC; Leavitt T; Schottenfeld D; Engle RL; Levy M
Am J Epidemiol; 1983 Jan; 117(1):35-45. PubMed ID: 6823951
[TBL] [Abstract] [Full Text] [Related]
